3,4-dihydroxyphenylacetic acid has been researched along with quinine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Antkiewicz-Michaluk, L; Lorenc-Koci, E; Wardas, J; Wierońska, J; Zapała, M | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and quinine
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic sy
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Oxidoreductases; Animals; Aryl Hydrocarbon Hydroxylases; Autoradiography; Behavior, Animal; Blotting, Western; Corpus Striatum; Cytochrome P450 Family 2; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Drug Interactions; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Piperazines; Protein Binding; Psychomotor Performance; Quinine; Rats; Rats, Wistar; Substantia Nigra; Tetrahydroisoquinolines; Time Factors; Tritium; Tyrosine 3-Monooxygenase | 2004 |